You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Novel Antagonists for Ameliorating Pulmonary Fibrosis

    SBC: AUXAGEN, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Pulmonary fibrosis, a group of incurable lung diseases with high mortality rates, is characterized by inflammatory cell infiltration, fibroblast proliferation, and excessive deposition of extracellular matrix proteins in lung parenchyma. Globally, five million people are affected by pulmonary fibrosis. In the U.S. alone, 200,000 suffer from this disease. Of the ...

    STTR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health
  2. Fast Biosequence Annotation via Reconfigurable Hardware

    SBC: BECS Technology, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Databases of biological sequences have proven valuable for understanding the organization of human and other genomes, for unraveling the etiology of genetic disorders, and for studying medically important pathogens. Unfortunately, these databases are growing at an exponential rate, posing a severe problem for bio-sequence annotation. Specialized hardware implem ...

    STTR Phase II 2007 Department of Health and Human ServicesNational Institutes of Health
  3. Innovative Methods for Function and Disability Assessment

    SBC: CreCare, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): The objective of this proposed project is to transform the data collection technology used to assess function and disability in older adults. The proposal responds to NIA's stated priority listed in PA-04-064 to "develop new products that improve data collection, data analysis, and data dissemination of gerontological research." Traditional, fixed-form outcome ...

    STTR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health
  4. Physics-Based Identification and Management of Aeroelastic Limit-Cycle Oscillations (LCO)

    SBC: EQUILIBRIA            Topic: AF07T006

    The objective of the proposed effort is to develop a systematic approach for building reduced-order models (nonlinear coupled finite-degree-of-freedom equations) capable of reliably modeling and predicting limit cycle oscillations (LCOs) and using these models in LCO management procedures. The models will be developed by combining (a) physical observations from ground vibration, wind tunnel, and ...

    STTR Phase I 2007 Department of DefenseAir Force
  5. Rapid homogeneous antibody-based detection of proteins

    SBC: MEDIOMICS, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Detection of the presence and the determination of the amount of a specific protein using various techniques utilizing antibodies specific to the target protein are one of the most important tools in biomedical research, medical diagnosis and detection of biological threat agents. These techniques (such as, for example, ELISA) take advantage of the exquisite sp ...

    STTR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health
  6. High Throughput Drug Screening in Drosophila for Novel Diabetes Therapeutics

    SBC: MEDROS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Diabetes mellitus and related metabolic syndrome represent perhaps the fastest growing major disease market in the developing world. Diabetes has recently been described as "a global pandemic" that affects nearly 200 million people worldwide and costs this country more than $130 billion. Diabetes is a chronic disease characterized by a series of metabolic defec ...

    STTR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health
  7. Bone-Conducted Sound Transmission and Attenuation

    SBC: CREARE LLC            Topic: AF06T035

    Hearing protection for personnel working in high-noise environments presents an important challenge for the scientific and engineering community. Air Force maintenance personnel working in close proximity to operating jet aircraft can be exposed to sound levels approaching 150 dBA. At these levels, the attenuation provided by hearing protection devices (HPDs) is limited by bone-conducted sound th ...

    STTR Phase II 2007 Department of DefenseAir Force
  8. Quantum Dots in Optical Cavities for Sharp and Variable Spectral Response

    SBC: QMAGIQ LLC            Topic: AF07T027

    We propose to embed quantum dots in resonant optical cavities to sharpen their spectral respone and provide a mechanism to spatially vary it across an infrared detector array. This project will combine the self-assembled-quantum-dot epitaxy expertise of Professor Towe's group at Carnegie Mellon University with the infrared focal plane array design, fabrication, and test expertise of QmagiQ. Phas ...

    STTR Phase I 2007 Department of DefenseAir Force
  9. Samaritan Compounds Suppress Viral Replication and Prevent Neuronal Damage

    SBC: SAMARITAN PHARMACEUTICALS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Currently up to 50% of HIV infected individuals including those taking antiretroviral therapy have mild neurocognitive disorder. Furthermore, the population living with HIV infection continues to grow and there are now over one million people living with HIV in the US and 42 million around the world. This indicates that persistent HIV associated cognitive impai ...

    STTR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health
  10. Syrian Hamster as a Permissive Model for Testing Anti-Adenovirus Drugs

    SBC: VIRRX, INC            Topic: N/A

    DESCRIPTION (provided by applicant): Human adenoviruses (Ads) are a significant problem in immunosuppressed humans, especially in children undergoing allogeneic stem cell transplants. About 20% of these pediatric patients develop disseminated Ad infections and about half of the patients die. There are no anti-viral drugs approved to treat these Ad infections. Cidofovir and ribavirin are used in so ...

    STTR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government